EMP3 and central nervous system cancer: The expression of S100A4, EMP3, and PLAUR was increased in recurrent gliomas compared with primary gliomas (Supplementary Figures S1A–C) as were the risk scores of recurrent gliomas (Supplementary Figure S1D).